TD Waterhouse Canada Inc. - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
TD Waterhouse Canada Inc. ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$57,868
+26.5%
40,5530.0%0.00%
Q2 2023$45,743
+3860.4%
40,553
+2511.3%
0.00%
Q1 2023$1,155
-8.6%
1,5530.0%0.00%
Q4 2022$1,263
+99.5%
1,5530.0%0.00%
Q3 2022$633
-15.1%
1,5530.0%0.00%
Q2 2022$746
-40.6%
1,5530.0%0.00%
Q1 2022$1,256
-67.6%
1,553
+20.3%
0.00%
Q4 2021$3,8741,2910.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders